Possible way to treat ovarian cancer reported
By Megan Rauscher
NEW YORK (Reuters Health) - Blocking certain proteins in cells may be a way to attack ovarian cancer, researchers said at the annual meeting of the American Society for Cell Biology underway in San Francisco.
For growth and proliferation, ovarian cancer cells are “addicted” to a family of proteins produced by the cancer-promoting gene MYC, according to lead researcher Dr. Tulsiram Prathapam, a cell biologist from the University of California, Berkeley.
Importantly, Prathapam told Reuters Health, “Our results suggest that inhibition of MYC and MYC family members will have significant therapeutic value in the treatment of ovarian cancer.”
The MYC ‘oncogene’ is amplified in 30 percent to 60 percent of human ovarian tumors. Prathapam and colleagues observed that MYC-amplified ovarian cancer cell lines are dependent on MYC expression for continued proliferation, whereas MYC non-amplified ovarian cancer cell lines are dependent on expression of related MYC family members for continued proliferation.
The researchers found that blocking MYC inhibited ovarian tumor cell proliferation in MYC-amplified cell lines, and silencing all related MYC ‘isoforms’ led to growth arrest of MYC non-amplified ovarian cancer cells.
Prathapam’s team also observed that blocking the MYC family of proteins in normal ovarian surface cells did not affect their ability to grow.
A logical next step, Prathapam noted, would be to see if the strategy blocks ovarian tumor growth in mice.
--------------------------------------------------------------------------------------------Related Posts:
LONDON (Reuters) - A gene involved in cell division also helps fuel a deadly childhood cancer called neuroblastoma and could offer a new way to develop drugs to treat the disease, German researchers said on Monday. The study published in the journal Cancer Cell found that a protein produced by the AURKA gene feeds a different
Full Post: Study sheds light on deadly childhood cancer
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - A new type of imaging compound can literally light up spreading cancer cells and may offer a way to track the deadly spread of the disease, Japanese and U.S. researchers reported on Sunday. They used the new compound to monitor the spread of breast and ovarian cancer cells in living mice, using a
Full Post: Compound lights up spreading cancer cells
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - Lung cancer cells produce a compound that helps the tumor spread to other parts of the body, a finding that could lead to a new way to prevent this dangerous development, researchers reported on Wednesday. They said a protein called versican hijacks elements of the immune system, generating inflammation that can
Full Post: Study points to way of stopping lung cancer spread
--------------------------------------------------------------------------------------------
LONDON (Reuters) - A technique using a tiny glass window implanted on the skin of a mouse allows scientists to track individual cancer cells as they spread and attack other parts of the body, according to a study published on Sunday. This window could one day play a big role in analyzing how well developmental
Full Post: Glass implant on tumor helps track cancer in mice
--------------------------------------------------------------------------------------------
LONDON (Reuters) - The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein which makes cells stick together, British researchers said on Thursday. The findings could lead to new tests to determine which women are not likely to benefit from tamoxifen and
Full Post: Study sheds light on breast cancer drug failure